迷幻产业的诞生:利用迷幻文艺复兴

Minsu Yoo, Sofia Sakopoulos
{"title":"迷幻产业的诞生:利用迷幻文艺复兴","authors":"Minsu Yoo,&nbsp;Sofia Sakopoulos","doi":"10.1002/fhu2.70004","DOIUrl":null,"url":null,"abstract":"<p>The resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by changes in legal frameworks, public attitudes, and an influx of venture capital (VC). This article explores the interplay between scientific innovation and capital investment within the psychedelic sector, highlighting how private funding shapes the form of research and its financialization. The study investigates the roles of VC and private interests in driving the psychedelic renaissance, examining how these financial forces influence ethical considerations and broader socio-political implications. Through in-depth interviews with key stakeholders in the industry, including in-house scientists and investors, the research uncovers how market-driven imperatives and financial conflicts of interest shape both scientific practices and public perceptions of psychedelic medicine—and how these perceptions, in turn, influence the industry. The analysis underscores the tension between the idealistic and capitalist narratives surrounding psychedelic medicine, suggesting that the psychedelic industry reflects broader trends in biotech and pharmaceutical industries, where innovation is closely tied to financial investment and market dynamics. At the same time, it highlights the paradox of psychedelic mysticism, which remains elusive to the rigid criteria of evidence-based medicine, thereby challenging the prevailing paradigm of psychopharmacological research. The findings call for a critical examination, through continuous public engagement, of the ethical dimensions of integrating psychedelics into mainstream medicine, highlighting the need to focus on the emergence of grey areas within capital networks where cultural and political values are constantly rearranged and restructured.</p>","PeriodicalId":100563,"journal":{"name":"Future Humanities","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/fhu2.70004","citationCount":"0","resultStr":"{\"title\":\"The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance\",\"authors\":\"Minsu Yoo,&nbsp;Sofia Sakopoulos\",\"doi\":\"10.1002/fhu2.70004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by changes in legal frameworks, public attitudes, and an influx of venture capital (VC). This article explores the interplay between scientific innovation and capital investment within the psychedelic sector, highlighting how private funding shapes the form of research and its financialization. The study investigates the roles of VC and private interests in driving the psychedelic renaissance, examining how these financial forces influence ethical considerations and broader socio-political implications. Through in-depth interviews with key stakeholders in the industry, including in-house scientists and investors, the research uncovers how market-driven imperatives and financial conflicts of interest shape both scientific practices and public perceptions of psychedelic medicine—and how these perceptions, in turn, influence the industry. The analysis underscores the tension between the idealistic and capitalist narratives surrounding psychedelic medicine, suggesting that the psychedelic industry reflects broader trends in biotech and pharmaceutical industries, where innovation is closely tied to financial investment and market dynamics. At the same time, it highlights the paradox of psychedelic mysticism, which remains elusive to the rigid criteria of evidence-based medicine, thereby challenging the prevailing paradigm of psychopharmacological research. The findings call for a critical examination, through continuous public engagement, of the ethical dimensions of integrating psychedelics into mainstream medicine, highlighting the need to focus on the emergence of grey areas within capital networks where cultural and political values are constantly rearranged and restructured.</p>\",\"PeriodicalId\":100563,\"journal\":{\"name\":\"Future Humanities\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/fhu2.70004\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Humanities\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fhu2.70004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Humanities","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fhu2.70004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

迷幻药的复苏,通常被称为“迷幻药复兴”,标志着从几十年的压抑研究到一个以重大科学、监管和经济变革为特征的新兴领域的深刻转变。迷幻药一度被边缘化,但在法律框架、公众态度的变化和风险资本(VC)的涌入的刺激下,迷幻药现在正经历着广泛的兴趣和投资。本文探讨了迷幻行业内科学创新和资本投资之间的相互作用,强调了私人资金如何塑造研究形式及其金融化。这项研究调查了风险投资和私人利益在推动迷幻药复兴中的作用,研究了这些金融力量如何影响伦理考虑和更广泛的社会政治含义。通过对行业主要利益相关者(包括内部科学家和投资者)的深入访谈,该研究揭示了市场驱动的必要性和财务利益冲突如何影响科学实践和公众对迷幻药的看法,以及这些看法如何反过来影响行业。该分析强调了围绕迷幻药的理想主义和资本主义叙事之间的紧张关系,表明迷幻药行业反映了生物技术和制药行业的更广泛趋势,这些行业的创新与金融投资和市场动态密切相关。同时,它强调了迷幻神秘主义的悖论,它仍然难以捉摸的严格的循证医学标准,从而挑战了精神药理学研究的主流范式。研究结果呼吁通过持续的公众参与,对将致幻剂纳入主流医学的伦理层面进行批判性审查,强调需要关注资本网络中出现的灰色地带,在那里文化和政治价值观不断被重新安排和重组。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance

The resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by changes in legal frameworks, public attitudes, and an influx of venture capital (VC). This article explores the interplay between scientific innovation and capital investment within the psychedelic sector, highlighting how private funding shapes the form of research and its financialization. The study investigates the roles of VC and private interests in driving the psychedelic renaissance, examining how these financial forces influence ethical considerations and broader socio-political implications. Through in-depth interviews with key stakeholders in the industry, including in-house scientists and investors, the research uncovers how market-driven imperatives and financial conflicts of interest shape both scientific practices and public perceptions of psychedelic medicine—and how these perceptions, in turn, influence the industry. The analysis underscores the tension between the idealistic and capitalist narratives surrounding psychedelic medicine, suggesting that the psychedelic industry reflects broader trends in biotech and pharmaceutical industries, where innovation is closely tied to financial investment and market dynamics. At the same time, it highlights the paradox of psychedelic mysticism, which remains elusive to the rigid criteria of evidence-based medicine, thereby challenging the prevailing paradigm of psychopharmacological research. The findings call for a critical examination, through continuous public engagement, of the ethical dimensions of integrating psychedelics into mainstream medicine, highlighting the need to focus on the emergence of grey areas within capital networks where cultural and political values are constantly rearranged and restructured.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信